StockNews.com Begins Coverage on Cytosorbents (NASDAQ:CTSO)
Stock analysts at StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO – Get Free Report) in a research report issued to clients and investors on Sunday. The brokerage set a “hold” rating on the medical research company’s stock. A number of other research firms have also weighed in on CTSO. D. Boral Capital reaffirmed a […]
More Stories
Cantor Fitzgerald Reiterates Overweight Rating for Rivian Automotive (NASDAQ:RIVN)
Rivian Automotive (NASDAQ:RIVN – Get Free Report)‘s stock had its “overweight” rating restated by Cantor Fitzgerald in a report issued...
The Goldman Sachs Group Initiates Coverage on ServiceTitan (NASDAQ:TTAN)
Stock analysts at The Goldman Sachs Group assumed coverage on shares of ServiceTitan (NASDAQ:TTAN – Get Free Report) in a...
Oppenheimer Raises Atlassian (NASDAQ:TEAM) Price Target to $300.00
Atlassian (NASDAQ:TEAM – Get Free Report) had its target price lifted by equities researchers at Oppenheimer from $270.00 to $300.00...
Truist Financial Issues Pessimistic Forecast for PotlatchDeltic (NASDAQ:PCH) Stock Price
PotlatchDeltic (NASDAQ:PCH – Get Free Report) had its price target cut by Truist Financial from $45.00 to $44.00 in a...
Argus Forecasts Strong Price Appreciation for Netflix (NASDAQ:NFLX) Stock
Netflix (NASDAQ:NFLX – Get Free Report) had its target price raised by investment analysts at Argus from $840.00 to $1,040.00...
MongoDB (NASDAQ:MDB) Upgraded to “Buy” at Guggenheim
MongoDB (NASDAQ:MDB – Get Free Report) was upgraded by Guggenheim from a “neutral” rating to a “buy” rating in a...